Lincoln Pharmaceuticals Ltd EPS

Lincoln Pharmaceuticals Ltd EPS

Image

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN

EPS

₹ 48.38

Last updated on: Oct 30, 2026

Key Highlights

  • The Earning per Share of Lincoln Pharmaceuticals Ltd is ₹ 48.38 as of 30 Oct 26 The earning per share of Lincoln Pharmaceuticals Ltd changed from ₹ 11.82 to ₹ 10.2 over 10 quarters. This represents a CAGR of -5.73% .

Historical Earning per Share of Lincoln Pharmaceuticals Ltd

No data available

* All values are in ₹

Company Fundamentals for Lincoln Pharmaceuticals Ltd

Market Cap

1,005 Cr

EPS

48.4

P/E Ratio (TTM)

10.4

P/B Ratio (TTM)

1.2

Day’s High

522.1

Day’s Low

497.0

DTE

0.0

ROE

11.9

52 Week High

770.0

52 Week Low

439.95

ROCE

15.7

Market Price of Lincoln Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Lincoln Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
30 Oct 2026501.95
29 Oct 2026511.85
28 Oct 2026557.55
27 Oct 2026549.75
26 Oct 2026526.75
23 Oct 2026514.7
22 Oct 2026512
21 Oct 2026515.85
19 Oct 2026532.8
16 Oct 2026546.5

SWOT Analysis Of Lincoln Pharmaceuticals Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Lincoln Pharmaceuticals Ltd

Asset Value vs Market Value of Lincoln Pharmaceuticals Ltd

Market Value

₹ 1,005

Asset Value

Value addition

1.7 X

₹ 375

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Lincoln Pharmaceuticals Ltd1005
Sun Pharmaceutical Industries Ltd426662
Divis Laboratories Ltd257903
Torrent Pharmaceuticals Ltd176306
Laurus Labs Ltd129243
Zydus Lifesciences Ltd124089

Historical Market Cap of Lincoln Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Historical Revenue of Lincoln Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Lincoln Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Lincoln Pharmaceuticals Ltd

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Lincoln Pharmaceuticals Ltd News Hub

Lincoln Pharmaceuticals consolidated net profit rises 24.51% in the June 2024 quarter

Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended June 2024 a

Read more

09 Aug 24

Lincoln Pharmaceuticals AGM scheduled

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

03 Sept 24

Lincoln Pharmaceuticals announces board meeting date

Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November

Read more

07 Nov 24

Lincoln Pharmaceuticals to conduct AGM

Lincoln Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

03 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Lincoln Pharmaceuticals Ltd

What is the EPS of Lincoln Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Lincoln Pharmaceuticals Ltd is 48.38. An EPS is the amount of net income attributed to each share of a common stock.

How is Lincoln Pharmaceuticals Ltd EPS calculated?

The EPS of Lincoln Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Lincoln Pharmaceuticals Ltd report its EPS?

Lincoln Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Lincoln Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Lincoln Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Lincoln Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Lincoln Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions